METTL18
gene geneOn this page
Also known as MGC9084AsTP2HPM1
Summary
METTL18 (methyltransferase 18, RPL3 N3(tau)-histidine, HGNC:28793) is a protein-coding gene on chromosome 1q24.2, encoding Histidine protein methyltransferase 1 homolog (O95568). Protein-L-histidine N-tele-methyltransferase that specifically monomethylates RPL3, thereby regulating translation elongation.
Enables heat shock protein binding activity and protein-L-histidine N-tele-methyltransferase activity. Involved in peptidyl-lysine monomethylation; regulation of gene expression; and regulation of ribosome biogenesis. Located in cytosol and nucleolus. Part of protein-containing complex.
Source: NCBI Gene 92342 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_033418
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28793 |
| Approved symbol | METTL18 |
| Name | methyltransferase 18, RPL3 N3(tau)-histidine |
| Location | 1q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC9084, AsTP2, HPM1 |
| Ensembl gene | ENSG00000171806 |
| Ensembl biotype | protein_coding |
| OMIM | 615255 |
| Entrez | 92342 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 protein_coding
ENST00000303469, ENST00000310392, ENST00000454472, ENST00000910251, ENST00000910252, ENST00000910253, ENST00000910254, ENST00000937804, ENST00000937805
RefSeq mRNA: 3 — MANE Select: NM_033418
NM_001320199, NM_001320201, NM_033418
CCDS: CCDS1284
Canonical transcript exons
ENST00000310392 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001173049 | 169792529 | 169793897 |
| ENSE00001192697 | 169794815 | 169794907 |
Expression profiles
Bgee: expression breadth ubiquitous, 271 present calls, max score 87.23.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.5402 / max 104.1038, expressed in 1500 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 15864 | 4.1640 | 1474 |
| 15863 | 0.3762 | 199 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.23 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.58 | gold quality |
| tendon | UBERON:0000043 | 84.33 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.70 | gold quality |
| granulocyte | CL:0000094 | 82.77 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 82.47 | gold quality |
| nasopharynx | UBERON:0001728 | 82.45 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 81.72 | gold quality |
| hair follicle | UBERON:0002073 | 81.58 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 81.41 | gold quality |
| amniotic fluid | UBERON:0000173 | 81.37 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 80.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.27 | gold quality |
| lymph node | UBERON:0000029 | 79.97 | gold quality |
| ventricular zone | UBERON:0003053 | 78.63 | gold quality |
| parietal pleura | UBERON:0002400 | 78.55 | gold quality |
| spleen | UBERON:0002106 | 78.31 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 78.31 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.92 | gold quality |
| cortical plate | UBERON:0005343 | 77.78 | gold quality |
| rectum | UBERON:0001052 | 77.67 | gold quality |
| pleura | UBERON:0000977 | 76.98 | gold quality |
| endothelial cell | CL:0000115 | 76.93 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 76.92 | gold quality |
| pancreas | UBERON:0001264 | 76.88 | gold quality |
| leukocyte | CL:0000738 | 76.46 | gold quality |
| oral cavity | UBERON:0000167 | 76.41 | gold quality |
| endometrium | UBERON:0001295 | 76.27 | gold quality |
| body of pancreas | UBERON:0001150 | 75.92 | gold quality |
| skin of hip | UBERON:0001554 | 75.88 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 122.69 |
| E-ANND-3 | no | 2.22 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Human METTL18 is a histidine-specific methyltransferase that targets RPL3 and affects ribosome biogenesis and function. (PMID:33693809)
- METTL18-mediated histidine methylation of RPL3 modulates translation elongation for proteostasis maintenance. (PMID:35674491)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mettl18 | ENSDARG00000074588 |
| mus_musculus | Mettl18 | ENSMUSG00000041396 |
| rattus_norvegicus | Mettl18 | ENSRNOG00000025189 |
| drosophila_melanogaster | CG17219 | FBGN0031494 |
| caenorhabditis_elegans | WBGENE00010450 |
Protein
Protein identifiers
Histidine protein methyltransferase 1 homolog — O95568 (reviewed: O95568)
Alternative names: Arsenic-transactivated protein 2, Methyltransferase-like protein 18
All UniProt accessions (2): O95568, Q5TI78
UniProt curated annotations — full annotation on UniProt →
Function. Protein-L-histidine N-tele-methyltransferase that specifically monomethylates RPL3, thereby regulating translation elongation. Histidine methylation of RPL3 regulates translation elongation by slowing ribosome traversal on tyrosine codons: slower elongation provides enough time for proper folding of synthesized proteins and prevents cellular aggregation of tyrosine-rich proteins.
Subunit / interactions. Interacts with GRWD1 and members of the heat shock protein 90 and 70 families; these proteins may possibly be methylation substrates for the enzyme.
Subcellular location. Cytoplasm. Cytosol. Nucleus. Nucleolus.
Post-translational modifications. Monomethylated at His-154 through automethylation. Automethylation at His-154 positively regulates the methyltransferase activity toward RPL3. Probably methylated on other residues.
Similarity. Belongs to the methyltransferase superfamily. METTL18 family.
RefSeq proteins (3): NP_001307128, NP_001307130, NP_219486* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019410 | Methyltransf_16 | Family |
| IPR029063 | SAM-dependent_MTases_sf | Homologous_superfamily |
Pfam: PF13489
Catalyzed reactions (Rhea), 1 shown:
- L-histidyl-[protein] + S-adenosyl-L-methionine = N(tele)-methyl-L-histidyl-[protein] + S-adenosyl-L-homocysteine + H(+) (RHEA:19369)
UniProt features (50 total): strand 15, helix 11, binding site 5, sequence variant 5, mutagenesis site 4, modified residue 3, region of interest 2, compositionally biased region 2, chain 1, short sequence motif 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4RFQ | X-RAY DIFFRACTION | 2.4 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95568-F1 | 74.51 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (5): 293; 168–172; 195; 216–218; 268–270
Post-translational modifications (3): 72, 77, 154
Mutagenesis-validated functional residues (4):
| Position | Phenotype |
|---|---|
| 154 | no effect on automethylation. loss of protein-l-histidine n-tele-methyltransferase activity toward rpl3. |
| 193–197 | abolished protein-l-histidine n-tele-methyltransferase activity. |
| 217 | loss of protein-l-histidine n-tele-methyltransferase activity. |
| 250–251 | decreased localization to the nucleus. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 117 (showing top):
GOBP_RIBOSOME_BIOGENESIS, BORCZUK_MALIGNANT_MESOTHELIOMA_UP, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOBP_PEPTIDYL_LYSINE_MODIFICATION, WCTCNATGGY_UNKNOWN, GOBP_TRANSLATIONAL_ELONGATION, GOBP_METHYLATION, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_PEPTIDYL_LYSINE_METHYLATION, FOX_Q2, GOBP_REGULATION_OF_TRANSLATION
GO Biological Process (7): regulation of translation (GO:0006417), regulation of translational elongation (GO:0006448), peptidyl-lysine monomethylation (GO:0018026), regulation of ribosome biogenesis (GO:0090069), regulation of rRNA processing (GO:2000232), cytoplasmic translation (GO:0002181), methylation (GO:0032259)
GO Molecular Function (5): protein-L-histidine N-tele-methyltransferase activity (GO:0018064), heat shock protein binding (GO:0031072), protein binding (GO:0005515), methyltransferase activity (GO:0008168), transferase activity (GO:0016740)
GO Cellular Component (5): nucleus (GO:0005634), nucleolus (GO:0005730), cytosol (GO:0005829), protein-containing complex (GO:0032991), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| translation | 2 |
| cellular anatomical structure | 2 |
| post-transcriptional regulation of gene expression | 1 |
| regulation of protein metabolic process | 1 |
| translational elongation | 1 |
| regulation of translation | 1 |
| peptidyl-lysine methylation | 1 |
| ribosome biogenesis | 1 |
| regulation of cellular component biogenesis | 1 |
| rRNA processing | 1 |
| regulation of gene expression | 1 |
| regulation of RNA metabolic process | 1 |
| metabolic process | 1 |
| N-methyltransferase activity | 1 |
| protein methyltransferase activity | 1 |
| S-adenosylmethionine-dependent methyltransferase activity | 1 |
| protein binding | 1 |
| binding | 1 |
| transferase activity, transferring one-carbon groups | 1 |
| catalytic activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| cytoplasm | 1 |
| cellular_component | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
986 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| METTL18 | METTL21A | Q8WXB1 | 735 |
| METTL18 | METTL22 | Q9BUU2 | 717 |
| METTL18 | VCPKMT | Q9H867 | 717 |
| METTL18 | RPL3 | P39023 | 705 |
| METTL18 | ETFBKMT | Q8IXQ9 | 687 |
| METTL18 | KIN | O60870 | 665 |
| METTL18 | METTL9 | Q9H1A3 | 651 |
| METTL18 | METTL23 | Q86XA0 | 628 |
| METTL18 | EEF1AKMT3 | Q96AZ1 | 601 |
| METTL18 | EEF2KMT | Q96G04 | 601 |
| METTL18 | METTL21C | Q5VZV1 | 592 |
| METTL18 | EEF1AKMT2 | Q5JPI9 | 589 |
| METTL18 | CAMKMT | Q7Z624 | 585 |
| METTL18 | EEF1AKMT1 | Q8WVE0 | 571 |
| METTL18 | METTL27 | Q8N6F8 | 561 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRICKLE3 | SIAH2 | psi-mi:“MI:0914”(association) | 0.530 |
| PRICKLE3 | METTL18 | psi-mi:“MI:0914”(association) | 0.530 |
| METTL18 | rl3_rl3l_human | psi-mi:“MI:0915”(physical association) | 0.500 |
| B3GALT4 | METTL18 | psi-mi:“MI:0915”(physical association) | 0.370 |
| YAE1 | METTL18 | psi-mi:“MI:0915”(physical association) | 0.370 |
| METTL18 | RGS2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| SSX2 | SSX5 | psi-mi:“MI:0914”(association) | 0.350 |
| rl3_rl3l_human | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| S100B | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| CCL3 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| FNDC8 | ZNF609 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM45B | METTL18 | psi-mi:“MI:0914”(association) | 0.350 |
| TTC39A | METTL18 | psi-mi:“MI:0914”(association) | 0.350 |
| MND1 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| SMAD4 | SBNO1 | psi-mi:“MI:0914”(association) | 0.350 |
| PHKA2 | STK25 | psi-mi:“MI:0914”(association) | 0.350 |
| PTGES2 | COX7A2L | psi-mi:“MI:0914”(association) | 0.350 |
| FCGRT | WBP4 | psi-mi:“MI:0914”(association) | 0.350 |
| TAGAP | METTL18 | psi-mi:“MI:0914”(association) | 0.350 |
| IMPA1 | METTL18 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL3 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| PHYHIP | METTL18 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (66): LAMB4 (Co-fractionation), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), METTL18 (Two-hybrid), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-RNA), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), RPL3 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), METTL18 (Affinity Capture-MS)
ESM2 similar proteins: A4D126, A4II32, A6NDL7, A6QP81, B0K012, E1B8U2, E1BCH6, O55055, O95568, P50747, Q149N8, Q28IN4, Q2KIJ2, Q2T9W2, Q3U2J5, Q498D5, Q4AC99, Q4KM84, Q58DC7, Q5RE14, Q5VZV1, Q6DJF8, Q6GQ33, Q6GR37, Q6ZMV9, Q7SY78, Q7TPQ3, Q80WC9, Q8BLU2, Q8BSE0, Q8C436, Q8CDZ2, Q8K2I9, Q8NE18, Q8NFZ0, Q8WXB1, Q95LL7, Q96EN8, Q96LZ7, Q9BTF0
Diamond homologs: A2AA28, A4FV42, A4FV98, A4IGU3, A6NDL7, A6QP81, A7IQW5, D3YWP0, F4JNX3, O14118, O95568, P0CU27, P40389, P47163, P53970, Q28IN4, Q2KIJ2, Q4KM84, Q55DL2, Q58DC7, Q5BLD8, Q5RE14, Q5RJL2, Q5VZV1, Q6DJF8, Q86XA0, Q8BLU2, Q8C436, Q8CDZ2, Q8R1C6, Q8WXB1, Q96AZ1, Q9BUU2, Q9CQL0, Q9CZ09, Q9H867, Q4I2X5, Q7VAM5, Q9UTQ8, P38347
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
135 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:169793893:CAGCT:C | acceptor_gain | 0.9900 |
| 1:169793894:AGCT:A | acceptor_gain | 0.9800 |
| 1:169793896:CT:C | acceptor_gain | 0.9800 |
| 1:169793897:TC:T | acceptor_loss | 0.9800 |
| 1:169793898:C:A | acceptor_loss | 0.9800 |
| 1:169793898:C:CC | acceptor_gain | 0.9800 |
| 1:169793895:GCT:G | acceptor_gain | 0.9600 |
| 1:169793896:CTC:C | acceptor_gain | 0.9600 |
| 1:169793897:TCT:T | acceptor_gain | 0.9600 |
| 1:169793898:C:G | acceptor_gain | 0.9600 |
| 1:169794685:T:A | donor_gain | 0.9000 |
| 1:169794565:TA:T | donor_gain | 0.8900 |
| 1:169794150:TAC:T | donor_gain | 0.8600 |
| 1:169794199:G:C | donor_gain | 0.8600 |
| 1:169794628:T:C | donor_gain | 0.8600 |
| 1:169794648:CGGG:C | donor_gain | 0.8600 |
| 1:169794152:C:CT | donor_gain | 0.8500 |
| 1:169794346:ATGG:A | donor_gain | 0.8400 |
| 1:169793894:A:T | acceptor_gain | 0.8300 |
| 1:169794206:G:A | donor_gain | 0.8300 |
| 1:169794270:TC:T | donor_gain | 0.8200 |
| 1:169794324:C:A | donor_gain | 0.8200 |
| 1:169794149:C:CT | donor_gain | 0.8100 |
| 1:169794150:T:TT | donor_gain | 0.8100 |
| 1:169794153:C:CT | donor_gain | 0.8100 |
| 1:169794258:T:TA | donor_gain | 0.8100 |
| 1:169794243:T:C | donor_gain | 0.7900 |
| 1:169794614:C:A | donor_gain | 0.7900 |
| 1:169794631:A:AC | donor_gain | 0.7900 |
| 1:169794632:C:CC | donor_gain | 0.7900 |
AlphaMissense
2466 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:169792725:T:A | K324I | 0.997 |
| 1:169792888:A:G | W270R | 0.994 |
| 1:169792888:A:T | W270R | 0.994 |
| 1:169792727:G:C | S323R | 0.993 |
| 1:169792727:G:T | S323R | 0.993 |
| 1:169792729:T:G | S323R | 0.993 |
| 1:169792724:T:A | K324N | 0.992 |
| 1:169792724:T:G | K324N | 0.992 |
| 1:169792815:T:A | E294V | 0.992 |
| 1:169793172:A:G | L175P | 0.992 |
| 1:169793183:A:C | C171W | 0.991 |
| 1:169793189:C:A | W169C | 0.991 |
| 1:169793189:C:G | W169C | 0.991 |
| 1:169793191:A:G | W169R | 0.991 |
| 1:169793191:A:T | W169R | 0.991 |
| 1:169792712:A:C | F328L | 0.988 |
| 1:169792712:A:T | F328L | 0.988 |
| 1:169792714:A:G | F328L | 0.988 |
| 1:169793047:C:G | D217H | 0.988 |
| 1:169792886:C:A | W270C | 0.986 |
| 1:169792886:C:G | W270C | 0.986 |
| 1:169793108:A:C | C196W | 0.986 |
| 1:169793185:A:G | C171R | 0.985 |
| 1:169793046:T:G | D217A | 0.984 |
| 1:169792731:G:T | A322D | 0.983 |
| 1:169793100:C:T | G199D | 0.983 |
| 1:169792819:A:G | S293P | 0.982 |
| 1:169793109:C:T | C196Y | 0.982 |
| 1:169792613:C:A | R361S | 0.979 |
| 1:169792613:C:G | R361S | 0.979 |
dbSNP variants (sampled 300 via entrez): RS1000357893 (1:169795914 G>A,T), RS1001074639 (1:169792627 C>G,T), RS1001750158 (1:169795552 G>T), RS1003874865 (1:169793846 A>G), RS1005117596 (1:169796580 C>A,G,T), RS1005497624 (1:169795011 C>G,T), RS1007169086 (1:169796388 T>C), RS1007699631 (1:169792030 C>T), RS1008289849 (1:169793806 A>C,G), RS1008466643 (1:169794147 C>G), RS1008797172 (1:169792905 C>A,T), RS1010059911 (1:169794669 T>C,G), RS1010112457 (1:169794927 C>A), RS1010660820 (1:169792191 A>C,T), RS1012460739 (1:169792246 T>C)
Disease associations
OMIM: gene MIM:615255 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases methylation, affects expression, decreases expression | 4 |
| Vorinostat | decreases expression, increases expression | 2 |
| Air Pollutants | decreases expression, increases abundance, affects expression, affects cotreatment | 2 |
| Ozone | decreases expression, increases abundance, affects expression, affects cotreatment | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| 2,5,2’,5’-tetrachlorobiphenyl | increases expression | 1 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | affects expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| methacrylaldehyde | decreases expression, increases abundance, affects cotreatment | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| MT19c compound | increases expression | 1 |
| Resveratrol | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Acrolein | affects cotreatment, decreases expression, increases abundance | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Potassium Chloride | decreases response to substance, decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Dronabinol | decreases expression, decreases response to substance | 1 |
| Thimerosal | increases expression | 1 |
| Urethane | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | affects expression | 1 |
Cellosaurus cell lines
6 cell lines: 3 transformed cell line, 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_F1XD | HEK293T METTL18 KO | Transformed cell line | Female |
| CVCL_F1XF | HEK293T SETD3-METTL18 DKO | Transformed cell line | Female |
| CVCL_F1XG | HEK293T METTL18 KO METTL18-HA | Transformed cell line | Female |
| CVCL_SX96 | HAP1 METTL18 (-) 1 | Cancer cell line | Male |
| CVCL_SX97 | HAP1 METTL18 (-) 2 | Cancer cell line | Male |
| CVCL_SX98 | HAP1 METTL18 (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.